1
|
Park J, Ondusko DS, Chang BH, Edwards EA, Doan S, Gatter K, Hajjali I, Kim A. Fetal Hepatomegaly. Neoreviews 2022; 23:e861-e868. [PMID: 36450648 DOI: 10.1542/neo.23-12-e861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Affiliation(s)
- Jina Park
- Division of Neonatology, Oregon Health & Science University, Portland, OR
| | | | - Bill H Chang
- Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR
| | - Emily A Edwards
- Division of Diagnostic Radiology, Oregon Health & Science University, Portland, OR
| | - Sylvia Doan
- Division of Pediatric Gastroenterology, Oregon Health & Science University, Portland, OR
| | - Ken Gatter
- Division of Pathology, Oregon Health & Science University, Portland, OR
| | - Ibrahim Hajjali
- Division of Pathology, Oregon Health & Science University, Portland, OR
| | - Amanda Kim
- Division of Neonatology, Oregon Health & Science University, Portland, OR
| |
Collapse
|
2
|
Hallali G, Le HM, Souied E, Doan S. [Severe eyelid eczema secondary to intravenous obnituzumab treated successfully with tacrolimus cream: Case report]. J Fr Ophtalmol 2022; 45:e426-e427. [PMID: 35659427 DOI: 10.1016/j.jfo.2022.01.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 01/21/2022] [Accepted: 01/26/2022] [Indexed: 11/27/2022]
Affiliation(s)
- G Hallali
- Service d'ophtalmologie, hôpital intercommunal Henri-Mondor, université Paris-Est Créteil (UPEC, Paris XII), 40, avenue de Verdun, 94000 Créteil, France; Service d'ophtalmologie, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France.
| | - H M Le
- Service d'ophtalmologie, hôpital intercommunal Henri-Mondor, université Paris-Est Créteil (UPEC, Paris XII), 40, avenue de Verdun, 94000 Créteil, France
| | - E Souied
- Service d'ophtalmologie, hôpital intercommunal Henri-Mondor, université Paris-Est Créteil (UPEC, Paris XII), 40, avenue de Verdun, 94000 Créteil, France
| | - S Doan
- Service d'ophtalmologie, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France
| |
Collapse
|
3
|
Doan S, Arnould L, Febvay C, Fournié P, Gueudry J, Labalette P, Ouilhon C, Tran THC, Vabres B, Barbarot S, Bouaziz JD, Du-Thanh A, Jachiet M, Seneschal J, Soria A, Staumont-Sallé D, Baudouin C, Mortemousque B. Blépharo-conjonctivites sous dupilumab : recommandations du groupe CEDRE. Dermatite atopique, conjonctivites et dupilumab : quelle prise en charge ? J Fr Ophtalmol 2022; 45:277-287. [DOI: 10.1016/j.jfo.2021.12.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Accepted: 12/20/2021] [Indexed: 11/17/2022]
|
4
|
Egri S, Van Hollebecke I, Guindolet D, Manenti C, Rougier H, Gabison É, Cochereau I, Doan S. [Efficacy of intense pulsed light therapy in the treatment of Meibomian gland dysfunction-related severe dry eye]. J Fr Ophtalmol 2021; 44:169-175. [PMID: 33358077 DOI: 10.1016/j.jfo.2020.04.061] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Revised: 04/19/2020] [Accepted: 04/22/2020] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Dry eye syndrome caused by Meibomian gland dysfunction (MGD) is a common disease in the general population and impairs quality of life. Intense Pulsed Light (IPL) has mainly been used in dermatology for the treatment of skin disorders, and more recently for MGD-related dry eye. The objective of our study is to evaluate the efficacy and tolerability of IPL with the E-Eye® device (E-Swin, Houdan, France) in severe MGD-related dry eye patients. MATERIALS AND METHODS This non-comparative study included 20 patients with MGD-related dry eye with a Break-Up Time (BUT)<10seconds, dry eye symptoms >30mm on a Visual Analog Scale (VAS), and failure of lid hygiene and artificial tears. Treatment consisted of 3 sessions of IPL on D0, D15, and D45 (5 flashes of 13J/cm2 per eye). The following parameters were assessed at each visit and at D75 : symptoms graded with a VAS and the Standard Patient Assessment of Eye Dryness questionnaire (SPEED), BUT, corneal fluorescein staining, Meibomian gland expression score, meibography, tear film lipid layer thickness by interferometry and the ocular scattering index by double-pass aberrometry (OQAS). Statistical analysis was performed on the eye most affected at baseline. RESULTS We included 40 eyes of 20 patients, 15 female and 5 male, mean age 47±15 years (24 to 74 years). The symptoms rated by VAS were severe, averaging 69±25mm. After treatment, there was a statistically significant decrease in symptoms, with a 14mm VAS decrease (55±29mm at D75 versus 69mm at D0, P=0.048) and SPEED score of 3.4 (19.0±6mm versus 22.4±4.6, P=0.03). The number of expressible Meibomian gland ducts increased significantly (from 5.9 to 8.1, P=0.04), lid redness decreased (from 1.4 to 0.6, P=NS) and BUT improved (from 4.2 to 5.9, P=NS). Other parameters remained unchanged. Three patients (15%) complained of transient ocular burning after each treatment. CONCLUSION IPL appears to be effective in improving signs and symptoms in patients with severe MGD-related dry eye, with a good safety profile. Its exact mechanism of action remains to be elucidated.
Collapse
Affiliation(s)
- S Egri
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - I Van Hollebecke
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - D Guindolet
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - C Manenti
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - H Rougier
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - É Gabison
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - I Cochereau
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - S Doan
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France.
| |
Collapse
|
5
|
Combemale L, Alexandre M, Sitbon I, Pascal F, Soued I, Doan S, Caux F, Prost-Squarcioni C, Le Roux-Villet C. Lichen plan pemphigoïde avec atteinte muqueuse : étude de 12 cas. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
6
|
Ben Hadj Salah W, Baudouin C, Doan S, Angoulvant A, Gottlieb J, Bénichou J, Da Cunha E, Eid L, Labetoulle M, Rousseau A. [Demodex and ocular surface disease]. J Fr Ophtalmol 2020; 43:1069-1077. [PMID: 33127178 DOI: 10.1016/j.jfo.2020.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Revised: 08/08/2020] [Accepted: 08/24/2020] [Indexed: 12/12/2022]
Abstract
Demodex is a saprophytic mite of the ocular adnexa, which can in certain circumstances proliferate on the skin of the face and on the eyelid margins. It is involved in facial rosacea (especially in the papulopustular form) and in the development or aggravation of anterior and/or posterior blepharitis or even keratoconjunctivitis, often in association with cutaneous lesions ; the pathophysiology is often multifactorial. Symptoms are non-specific, but the presence of cylindrical sleeves on the eyelashes is very suggestive of infestation, and certain techniques of biomicroscopic examination or imaging, such as confocal microscopy in vivo, allow direct visualization of the parasite. Parasitological examination of the eyelashes can confirm the diagnosis and can be improved by good sampling technique. Eyelid hygiene and oil-based ointments are the cornerstone of treatment. New specific treatments, in particular topical treatments based on tea tree oil, ivermectin, as well as pulsed light therapy and micro-exfoliation of the eyelid margin, can help to reduce the parasitic load and improve symptoms.
Collapse
Affiliation(s)
- W Ben Hadj Salah
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - C Baudouin
- Services d'ophtalmologie, CHNO des XV-XX, et hôpital Ambroise-Paré, Assistance Publique-Hôpitaux de Paris, université Versailles-St-Quentin-en-Yvelines, IHU de Sight Restore Saclay, Paris, France; Institut de la vision, Sorbonne université, Inserm, CNRS, Sorbonne, France
| | - S Doan
- Service d'ophtalmologie, CHU de Bichat, Assistance Publique-Hôpitaux de Paris et Fondation ophtalmologique Rothschild, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - A Angoulvant
- Service de parasitologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, Paris, France
| | - J Gottlieb
- Service d'immunologie clinique & consultation de dermatologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, Paris, France
| | - J Bénichou
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - E Da Cunha
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - L Eid
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - M Labetoulle
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France; Département immunologie des maladies virales, auto-immunes, bactériennes et hématologiques (IMVA-HB). UMR 1184, CEA, Fontenay-Aux-Roses, France
| | - A Rousseau
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France; Département immunologie des maladies virales, auto-immunes, bactériennes et hématologiques (IMVA-HB). UMR 1184, CEA, Fontenay-Aux-Roses, France.
| |
Collapse
|
7
|
Affiliation(s)
- M Labetoulle
- Service d'ophtalmologie, hôpital de Bicêtre, 78, avenue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France; IDMIT Infrastructure, CEA, Université Paris Sacaly, Inserm U1184, 18, route du Panorama, 92265 Fontenay-aux-Roses cedex, France.
| | - S Doan
- Service d'ophtalmologie, hôpital de Bicêtre, 78, avenue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France; Hôpital Fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France
| | - A Rousseau
- Service d'ophtalmologie, hôpital de Bicêtre, 78, avenue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France; IDMIT Infrastructure, CEA, Université Paris Sacaly, Inserm U1184, 18, route du Panorama, 92265 Fontenay-aux-Roses cedex, France
| |
Collapse
|
8
|
Arndt C, Audrun F, Bodaghi B, Caujolle JP, Cassoux N, Defoort S, Delyfer MN, Denis P, Doan S, Fenolland JR, Giraud JM, Kodjikian L, Labetoulle M, Lasudry J, Leveziel N, Rousseau A, Saadoun D, Speeg-Schatz C, Touhami S, Touitou V, Vignal C, Zech C. [Categorization of the degree of urgency according to ophthalmology procedures or situations]. J Fr Ophtalmol 2020; 43:525-528. [PMID: 32409227 DOI: 10.1016/j.jfo.2020.04.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 04/27/2020] [Indexed: 11/19/2022]
Affiliation(s)
- C Arndt
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - F Audrun
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - B Bodaghi
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J-P Caujolle
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - N Cassoux
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - S Defoort
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - M-N Delyfer
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - P Denis
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - S Doan
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J-R Fenolland
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J-M Giraud
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - L Kodjikian
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France.
| | - M Labetoulle
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J Lasudry
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - N Leveziel
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - A Rousseau
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - D Saadoun
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - C Speeg-Schatz
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - S Touhami
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - V Touitou
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - C Vignal
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - C Zech
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| |
Collapse
|
9
|
Maillard A, Alby C, Aberdam D, Gabison E, Doan S, Bodermer C, Hadj-Rabia S. Dysplasies ectodermiques P63 : caractérisation dermatologique et corrélation génotype–phénotype. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
10
|
Roriz M, Alexandra J, Bertinchamp R, Chauveheid M, Cohen Aubart F, Doan S, Dossier A, Goulenok T, Klein I, Rouzaud D, Sacré K, Papo T. Syndrome de SUSAC : séquelles et absence de facteurs cliniques prédictifs. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
11
|
Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, Erkek S, Federation A, Song A, Lee C, Wang X, McDonald L, Morrow JJ, Saiakhova A, Sin-Chan P, Wu Q, Michaelraj KA, Miller TE, Hubert CG, Ryzhova M, Garzia L, Donovan L, Dombrowski S, Factor DC, Luu B, Valentim CLL, Gimple RC, Morton A, Kim L, Prager BC, Lee JJY, Wu X, Zuccaro J, Thompson Y, Holgado BL, Reimand J, Ke SQ, Tropper A, Lai S, Vijayarajah S, Doan S, Mahadev V, Miñan AF, Gröbner SN, Lienhard M, Zapatka M, Huang Z, Aldape KD, Carcaboso AM, Houghton PJ, Keir ST, Milde T, Witt H, Li Y, Li CJ, Bian XW, Jones DTW, Scott I, Singh SK, Huang A, Dirks PB, Bouffet E, Bradner JE, Ramaswamy V, Jabado N, Rutka JT, Northcott PA, Lupien M, Lichter P, Korshunov A, Scacheri PC, Pfister SM, Kool M, Taylor MD, Rich JN. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 2017; 553:101-105. [PMID: 29258295 PMCID: PMC5993422 DOI: 10.1038/nature25169] [Citation(s) in RCA: 152] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Accepted: 11/22/2017] [Indexed: 12/26/2022]
Abstract
Genomic sequencing has driven precision-based oncology therapy; however, genetic drivers remain unknown or non-targetable for many malignancies, demanding alternative approaches to identify therapeutic leads. Ependymomas are chemotherapy-resistant brain tumours, which, despite genomic sequencing, lack effective molecular targets. Intracranial ependymomas are segregated based on anatomical location – supratentorial region (ST) or posterior fossa (PF) – and further divided into distinct molecular subgroups that reflect differences in age of onset, gender predominance, and response to therapy1–3. The most common and aggressive subgroup, Posterior Fossa Ependymoma Group A (PF-EPN-A), occurs in young children and appears to lack recurrent somatic mutations2. Conversely, Posterior Fossa Ependymoma Group B (PF-EPN-B) tumours display frequent large-scale copy number gains and losses yet favourable clinical outcomes1,3. Greater than 70% of supratentorial ependymomas are defined by highly recurrent gene fusions in the NFκB subunit RELA (ST-EPN-RELA), and less frequently involve fusion of the gene encoding the transcriptional activator YAP1 (ST-EPN-YAP1).1,3,4 Subependymomas, a distinct histologic variant, can also be found within the ST and PF compartments accounting for the majority of tumours in the molecular subgroups ST-EPN-SE and PF-EPN-SE, respectively1. Here, we mapped active chromatin landscapes in 42 primary ependymomas in two non-overlapping primary ependymoma cohorts with the goal of identifying essential super enhancer associated genes on which tumour cells were dependent. Enhancer regions revealed putative oncogenes, molecular targets, and pathways, which when subjected to small molecule inhibitor or shRNA treatment, diminished proliferation of patient-derived neurospheres and increased survival in mouse models of ependymomas. Through profiling of transcriptional enhancers, our study provides a framework for target and drug discovery in other cancers recalcitrant to therapeutic development because of their lack of known genetic drivers.
Collapse
Affiliation(s)
- Stephen C Mack
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.,Department of Pediatric Hematolgy and Oncology, Texas Children's Cancer and Hematology Centers, Houston, Texas, USA.,Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Kristian W Pajtler
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.,Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, 69120 Heidelberg, Germany
| | - Lukas Chavez
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.,Department of Medicine, Division of Medical Genetics, University of California - San Diego School of Medicine, La Jolla, California 92093, USA
| | - Konstantin Okonechnikov
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
| | - Kelsey C Bertrand
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.,Department of Pediatric Hematolgy and Oncology, Texas Children's Cancer and Hematology Centers, Houston, Texas, USA.,Department of Pediatrics, Cleveland Clinic, Cleveland, Ohio 44195, USA
| | - Xiuxing Wang
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Medicine, Division of Regenerative Medicine, University of California - San Diego School of Medicine, La Jolla, California, USA
| | - Serap Erkek
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.,European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany
| | - Alexander Federation
- Department of Genomic Sciences, University of Washington, Seattle, Washington 355065, USA
| | - Anne Song
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Christine Lee
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Xin Wang
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Laura McDonald
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - James J Morrow
- Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Alina Saiakhova
- Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Patrick Sin-Chan
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Qiulian Wu
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Medicine, Division of Regenerative Medicine, University of California - San Diego School of Medicine, La Jolla, California, USA
| | - Kulandaimanuvel Antony Michaelraj
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Tyler E Miller
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Christopher G Hubert
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Marina Ryzhova
- Department of Neuropathology, NN Burdenko Neurosurgical Institute, 4th Tverskaya-Yamskaya 16, Moscow 125047, Russia
| | - Livia Garzia
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Laura Donovan
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Stephen Dombrowski
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic Neurological Institute, Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
| | - Daniel C Factor
- Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Betty Luu
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Claudia L L Valentim
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Ryan C Gimple
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Medicine, Division of Regenerative Medicine, University of California - San Diego School of Medicine, La Jolla, California, USA.,Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Andrew Morton
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Leo Kim
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Medicine, Division of Regenerative Medicine, University of California - San Diego School of Medicine, La Jolla, California, USA
| | - Briana C Prager
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Medicine, Division of Regenerative Medicine, University of California - San Diego School of Medicine, La Jolla, California, USA
| | - John J Y Lee
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Xiaochong Wu
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Jennifer Zuccaro
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Yuan Thompson
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Borja L Holgado
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Jüri Reimand
- Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.,Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada
| | - Susan Q Ke
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Adam Tropper
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Sisi Lai
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Senthuran Vijayarajah
- Department of Pediatrics, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Pediatrics, Division of Critical Care, University of Utah School of Medicine, Salt Lake City, Utah, USA
| | - Sylvia Doan
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA
| | - Vaidehi Mahadev
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
| | - Ana Fernandez Miñan
- Centro Andaluz de Biología del Desarrollo, Consejo Superior de Investigaciones Científicas and Universidad Pablo de Olavide, Sevilla, Spain
| | - Susanne N Gröbner
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
| | - Matthias Lienhard
- Department of Computational Molecular Biology, Max-Planck-Institute for Molecular Genetics, 14195 Berlin, Germany
| | - Marc Zapatka
- Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany
| | - Zhiqin Huang
- Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany
| | - Kenneth D Aldape
- Department of Pathology, University Health Network, Toronto, Ontario M5G 1L7, Canada
| | - Angel M Carcaboso
- Preclinical Therapeutics and Drug Delivery Research Program, Fundacio Sant Joan de Deu, 08950 Barcelona, Spain
| | - Peter J Houghton
- Nationwide Children's Hospital, Center for Childhood Cancer and Blood Diseases, Columbus, Ohio
| | - Stephen T Keir
- Duke University Medical Center, Department of Surgery, Durham, North Carolina, USA
| | - Till Milde
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, 69120 Heidelberg, Germany.,Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), INF 280, D-69120 Heidelberg, Germany
| | - Hendrik Witt
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.,Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, 69120 Heidelberg, Germany
| | - Yan Li
- Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Chao-Jun Li
- MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, National Resource Centre for Mutant Mice, Nanjing, China
| | - Xiu-Wu Bian
- Institute of Pathology and Southwest Cancer Center, Southwest Hospital, The Third Military Medical University, and The Key Laboratory of Tumor Immunopathology, The Ministry of Education of China, Chongqing, China
| | - David T W Jones
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
| | - Ian Scott
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Sheila K Singh
- Department of Surgery, Division of Neurosurgery, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
| | - Annie Huang
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.,Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA
| | - Peter B Dirks
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Eric Bouffet
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.,Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA
| | - James E Bradner
- Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA
| | - Vijay Ramaswamy
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.,Division of Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Nada Jabado
- Departments of Paediatrics and Human Genetics, McGill University and the McGill University Health Centre Research Institute, Montreal, Quebec H3Z 2Z3, Canada
| | - James T Rutka
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Paul A Northcott
- Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Mathieu Lupien
- Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada
| | - Peter Lichter
- Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany
| | - Andrey Korshunov
- Department of Neuropathology, University of Heidelberg, 69120 Heidelberg, Germany.,Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany
| | - Peter C Scacheri
- Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106, USA
| | - Stefan M Pfister
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.,Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, 69120 Heidelberg, Germany
| | - Marcel Kool
- Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany.,Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
| | - Michael D Taylor
- Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
| | - Jeremy N Rich
- Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.,Department of Medicine, Division of Regenerative Medicine, University of California - San Diego School of Medicine, La Jolla, California, USA.,Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic Neurological Institute, Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
| |
Collapse
|
12
|
Leonardi A, Doan S, Fauquert JL, Bozkurt B, Allegri P, Marmouz F, Rondon C, Jedrzejczak M, Hellings P, Delgado L, Calder V. Diagnostic tools in ocular allergy. Allergy 2017; 72:1485-1498. [PMID: 28387947 DOI: 10.1111/all.13178] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/04/2017] [Indexed: 12/21/2022]
Abstract
Ocular allergy (OA) includes a group of common and less frequent hypersensitivity disorders frequently misdiagnosed and not properly managed. The diagnosis of OA is usually based on clinical history and signs and symptoms, with the support of in vivo and in vitro tests when identification of the specific allergen is required. To date, no specific test is available for the diagnosis of the whole spectrum of the different forms of OA. The lack of recommendations on diagnosis of OA is considered a medical need not only for allergists but also for ophthalmologists. This position paper aims to provide a comprehensive overview of the currently available tools for diagnosing OA to promote a common nomenclature and procedures to be used by different specialists. Questionnaires, sign and symptom grading scales, tests, and potential biomarkers for OA are reviewed. We also identified several unmet needs in the diagnostic tools to generate interest, increase understanding, and inspire further investigations. Tools, recommendations, and algorithms for the diagnosis of OA are proposed for use by both allergists and ophthalmologists. Several unmet needs in the diagnostic tools should be further improved by specific clinical research in OA.
Collapse
Affiliation(s)
- A. Leonardi
- Department of Neuroscience; Ophthalmology Unit; University of Padua; Padua Italy
| | - S. Doan
- Service d'Ophtalmologie; Hôpital Bichat and Fondation A. de Rothschild; Paris France
| | - J. L. Fauquert
- Unité d'Allergologie de l'Enfant CHU Estaing; CHU Estaing; Clermont-Ferrand Cedex1 France
| | - B. Bozkurt
- Faculty of Medicine; Department of Ophthalmology; Selcuk University; Konya Turkey
| | - P. Allegri
- Rapallo Hospital Ophthalmology Department; Allergic Conjunctivitis Unit; Ocular Inflammatory Diseases Referral Center; Genova Italy
| | - F. Marmouz
- Pole sanitaire du Vexin; Pontoise France
| | - C. Rondon
- Allergy Unit; Regional University Hospital of Malaga; IBIMA, UMA; Malaga Spain
| | - M. Jedrzejczak
- Department of Immunology, Rheumatology and Allergy; Medical University of Lodz; Lodz Poland
| | | | - L. Delgado
- Laboratory of Immunology; Faculty of Medicine; Basic and Clinical Immunology Unit, and Center for Research in Health Technologies and Information Systems (CINTESIS); University of Porto; Porto Portugal
| | - V. Calder
- Department of Ocular Biology & Therapeutics; UCL Institute of Ophthalmology; London UK
| |
Collapse
|
13
|
Vitte J, Baye A, Batellier L, Doan S, Bury T. Molecular diagnostics of ocular allergy. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.03353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J. Vitte
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - A. Baye
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - L. Batellier
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - S. Doan
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - T. Bury
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| |
Collapse
|
14
|
Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, O'Cathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology 2017; 66:518-527. [PMID: 28390159 DOI: 10.1002/hep.29204] [Citation(s) in RCA: 126] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Revised: 02/07/2017] [Accepted: 04/04/2017] [Indexed: 12/14/2022]
Abstract
UNLABELLED There are limited data on the natural history of primary sclerosing cholangitis (PSC) in children. We aimed to describe the disease characteristics and long-term outcomes of pediatric PSC. We retrospectively collected all pediatric PSC cases from 36 participating institutions and conducted a survival analysis from the date of PSC diagnosis to dates of diagnosis of portal hypertensive or biliary complications, cholangiocarcinoma, liver transplantation, or death. We analyzed patients grouped by disease phenotype and laboratory studies at diagnosis to identify objective predictors of long-term outcome. We identified 781 patients, median age 12 years, with 4,277 person-years of follow-up; 33% with autoimmune hepatitis, 76% with inflammatory bowel disease, and 13% with small duct PSC. Portal hypertensive and biliary complications developed in 38% and 25%, respectively, after 10 years of disease. Once these complications developed, median survival with native liver was 2.8 and 3.5 years, respectively. Cholangiocarcinoma occurred in 1%. Overall event-free survival was 70% at 5 years and 53% at 10 years. Patient groups with the most elevated total bilirubin, gamma-glutamyltransferase, and aspartate aminotransferase-to-platelet ratio index at diagnosis had the worst outcomes. In multivariate analysis PSC-inflammatory bowel disease and small duct phenotypes were associated with favorable prognosis (hazard ratios 0.6, 95% confidence interval 0.5-0.9, and 0.7, 95% confidence interval 0.5-0.96, respectively). Age, gender, and autoimmune hepatitis overlap did not impact long-term outcome. CONCLUSION PSC has a chronic, progressive course in children, and nearly half of patients develop an adverse liver outcome after 10 years of disease; elevations in bilirubin, gamma-glutamyltransferase, and aspartate aminotransferase-to-platelet ratio index at diagnosis can identify patients at highest risk; small duct PSC and PSC-inflammatory bowel disease are more favorable disease phenotypes. (Hepatology 2017;66:518-527).
Collapse
Affiliation(s)
| | | | | | - Reham Abdou
- State University of New York Buffalo, Buffalo, NY
| | - Khaled Alqoaer
- Prince Salman North West Armed Forces Hospital, Tabuk, Saudi Arabia
| | - Mansi Amin
- University of California San Francisco, San Francisco, CA, and Texas Children's Hospital, Houston, TX
| | - Achiya Z Amir
- The Dana-Dwek Children's Hospital, The Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel
| | - Marcus Auth
- Alder Hey Children's Hospital, Liverpool, UK
| | | | | | - Albert Chan
- University of Rochester Medical Center, Rochester, NY
| | | | | | | | | | - Katryn N Furuya
- Mayo Clinic, Rochester, MN.,Nemours Alfred I duPont Hospital For Children, Wilmington, DE
| | | | | | - Nitika Gupta
- Emory University School of Medicine, Atlanta, GA
| | | | | | | | | | - Anastasia Konidari
- University of Liverpool, Liverpool, and University of Manchester, Manchester, UK
| | - Bart Koot
- Academic Medical Centre, Amsterdam, The Netherlands
| | | | - Oren Ledder
- Shaare Zedek Medical Center, Jerusalem, Israel
| | - Cara Mack
- University of Colorado School of Medicine, Aurora, CO
| | - Mercedes Martinez
- Columbia University College of Physicians and Surgeons, New York, NY
| | - Tamir Miloh
- Texas Children's Hospital, Houston, TX, and Phoenix Children's Hospital, Phoenix, AZ
| | | | | | | | | | | | - Pushpa Sathya
- Memorial University, St. John's, Newfoundland and Labrador, Canada
| | | | | | | | - Raghu Varier
- Northwest Pediatric Gastroenterology LLC, Portland, OR
| | - Veena Venkat
- University of Pittsburgh Medical Center, Pittsburgh, PA
| | | | - Miriam B Vos
- Emory University School of Medicine, Atlanta, GA
| | | | - Jason Yap
- University of Alberta, Edmonton, Alberta, Canada
| | | |
Collapse
|
15
|
Dubaut J, Doan S, Wild R, Craig L, Williams W. Fenbendazole treatment is associated with increased cycle fecundity rate in subfertile baboons. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.02.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
16
|
Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C, Calder V, Silva D, Kvenshagen BK, Callebaut I, Allegri P, Santos N, Doan S, Perez Formigo D, Chiambaretta F, Delgado L, Leonardi A. Conjunctival allergen provocation test : guidelines for daily practice. Allergy 2017; 72:43-54. [PMID: 27430124 DOI: 10.1111/all.12986] [Citation(s) in RCA: 57] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/14/2016] [Indexed: 01/15/2023]
Abstract
Conjunctival allergen provocation test (CAPT) reproduces the events occurring by instilling an allergen on the ocular surface. This paper is the compilation of a task force focussed on practical aspects of this technique based on the analysis of 131 papers. Main mechanisms involved are reviewed. Indications are diagnosing the allergen(s)-triggering symptoms in IgE-mediated ocular allergy in seasonal, acute or perennial forms of allergic conjunctivitis, especially when the relevance of the allergen is not obvious or in polysensitized patients. Contraindications are limited to ongoing systemic severe pathology, asthma and eye diseases. CAPT should be delayed if receiving systemic steroids or antihistamines. Local treatment should be interrupted according to the half-life of each drug. Prerequisites are as follows: obtaining informed consent; evidencing of an allergen by skin prick tests and/or serum-specific IgE dosages; being able to deal with an unlikely event such as acute asthma exacerbation, urticaria or anaphylaxis, or an exacerbation of allergic conjunctivitis. Allergen extracts should be diluted locally prior to administration. Positive criteria are based on itching or quoted according to a composite score. An alternative scoring is based on itching. CAPT remains underused in daily practice, although it is a safe and simple procedure which can provide valuable clinical information.
Collapse
Affiliation(s)
- J.-L. Fauquert
- Unité d'Allergologie de l'enfant; CHU Estaing; Clermont-Ferrand Cedex 1 France
| | | | - C. Rondon
- Allergy Unit; Regional University Hospital of Malaga; IBIMA; UMA; Malaga Spain
| | - V. Calder
- Department of Ocular Biology & Therapeutics (ORBIT); UCL Institute of Ophthalmology; London UK
| | - D. Silva
- Serviço de Imunoalergologia; Centro Hospitalar São João; E.P.E.; Porto Portugal
| | - B. K. Kvenshagen
- Pediatric Department; Oestfold Hospital Trust; Fredrikstad Norway
| | - I. Callebaut
- Clinical Immunology; Department of Microbiology and Immunology; Catholic University of Leuven; Leuven Belgium
| | - P. Allegri
- Allergic Conjunctivitis Unit; Ocular Inflammatory Diseases Referral Center; Rapallo Hospital Ophthalmological Dep.; Genova Italy
| | - N. Santos
- Serviço de Imunoalergologia; Centro Hospitalar São João; E.P.E.; Porto Portugal
| | - S. Doan
- Service d'Ophtalmologie; Hôpital Bichat and Fondation A. de Rothschild; Paris France
| | - D. Perez Formigo
- Servicio de Oftalmologia; Hospital Universitario de Torrejon; Madrid Spain
| | - F. Chiambaretta
- Service d'Ophtalmologie; CHU Montpied; Clermont-Ferrand Cedex 1 France
| | - L. Delgado
- Department of Immunology; Faculty of Medicine; University of Porto; Porto Portugal
| | - A. Leonardi
- Ophthalmology Unit; Department of Neuroscience; University of Padua; Padua Italy
| | | |
Collapse
|
17
|
Doan S, Zagórski Z, Palmares J, Yağmur M, Kaercher T, Van Dooren B, Jonckheere P, Jensen P, Benitez del Castillo J. Evaluation of the eyelid disorders in the daily ophthalmic practice in 9 European Countries: The MEIBUM* survey. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Doan S, Delcampe A. Moderate to severe dry eye - a promising indication for scleral lenses. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
19
|
Seta V, Alexandre M, Zumelzu C, Oro S, Bernardeschi C, Schneider P, Le Roux-Villet C, Pascal F, Weber P, Doan S, Soued I, Raynaud J, Benamouzig R, Vibert J, Tancrède E, Dupin N, Laroche L, Caux F, Tubach F, Prost-Squarcioni C, Gault N. Morbidité et facteurs pronostiques dans la pemphigoïde cicatricielle : étude de cohorte rétrospective. Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.03.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
20
|
Seta V, Gault N, Alexandre M, Zumelzu C, Oro S, Bernardeschi C, Schneider P, Le Roux Villet C, Pascal F, Weber P, Doan S, Soued I, Raynaud JJ, Lièvre N, Heller M, Tancrède E, Benamouzig R, Vibert JF, Dupin N, Wolkenstein P, Laroche L, Caux F, Tubach F, Prost-Squarcioni C. Morbidité et facteurs pronostiques dans la pemphigoïde cicatricielle : étude rétrospective sur 121 patients. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
21
|
Alexandre M, Seta V, Zumelzu C, Vibert JF, Le Roux Villet C, Doan S, Soued I, Pascal F, Lièvre N, Heller M, Caux F, Laroche L, Prost C. Efficacité du rituximab dans les pemphigoïdes des muqueuses. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
22
|
Rossi P, Delcampe A, Gueudry J, Duncombe A, Gabison E, Doan S, Muraine M. Traitement des sécheresses oculaires sévères secondaires à la maladie du greffon contre l’hôte chronique par lentilles sclérales perméables à l’oxygène. J Fr Ophtalmol 2015; 38:793-9. [DOI: 10.1016/j.jfo.2015.04.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2015] [Revised: 03/27/2015] [Accepted: 04/10/2015] [Indexed: 10/22/2022]
|
23
|
Stephan S, Rouger H, Doan S, Lamirel C, Cochereau I, Gabison E. Neurotrophic keratitis (NK) in carotid cavernous fistulae (CCF). Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- S. Stephan
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - H. Rouger
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - S. Doan
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - C. Lamirel
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - I. Cochereau
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - E. Gabison
- Ophtalmology; Fondation A. de Rothschild; Paris France
| |
Collapse
|
24
|
Doan S, Amat F, Gabison E, Just J, Cochereau I. Experience with the monoclonal anti IgE antibody Omalizumab in severe refractory vernal keratoconjunctivitis in children. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- S. Doan
- Ophthalmology; Hopital Bichat and Fondation A de Rothschild; Paris France
| | - F. Amat
- Allergology; Hopital Trousseau; Paris France
| | - E. Gabison
- Ophthalmology; Hopital Bichat and Fondation A de Rothschild; Paris France
| | - J. Just
- Allergology; Hopital Trousseau; Paris France
| | - I. Cochereau
- Ophthalmology; Hopital Bichat and Fondation A de Rothschild; Paris France
| |
Collapse
|
25
|
Diaz Valle D, Doan S, Yagmur M, Benitez del Castillo J. Eyelid disorders evaluation in the Ophthalmic current practice in Belgium, Denmark, France, Netherland, Portugal and Turkey: The Meibum Study. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- D. Diaz Valle
- Hospital Clinico San Carlos; Servicio de Oftalmologia; Madrid Spain
| | - S. Doan
- Départment ophthalmologie; Hôpital Bichat- Fondation A de Rothschild- Paris- France; Paris France
| | - M. Yagmur
- The Medicine Faculty Balcali Hospita; Cukurova University; Adana Turkey
| | | |
Collapse
|
26
|
Doan S, Baudouin C, Khairallah M. Randomised, controlled study of the efficacy and safety of a new eye-drop formulation for moderate to severe dry eye syndrome. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.1553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- S. Doan
- Hopital Bichat; Ophtalmologie; Paris France
| | - C. Baudouin
- CHNO des XV-XX; Service Ophtalmologie III; Paris France
| | - M. Khairallah
- Hôpital Fattouma Bourguiba; Service d'ophthalmologie; Monastir Tunisia
| |
Collapse
|
27
|
Doan S, Baudouin C, Khairallah M. Randomised, controlled study of the efficacy and safety of a new eye-drop formulation for moderate to severe dry eye syndrome. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- S. Doan
- Ophtalmologie; Hopital Bichat; Paris France
| | - C. Baudouin
- CHNO des XV-XX; Service Ophtalmologie III; Paris France
| | - M. Khairallah
- Hôpital Fattouma Bourguiba; Service d'ophthalmologie; Monastir Tunisia
| |
Collapse
|
28
|
Rousseau A, Labbé A, Baudouin C, Cochereau I, Gabison E, Doan S. In vivo confocal microscopy and spectral domain anterior segment OCT in Lisch epithelial corneal dystrophy. J Fr Ophtalmol 2015; 38:e151-3. [PMID: 26144589 DOI: 10.1016/j.jfo.2014.07.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2014] [Revised: 07/06/2014] [Accepted: 07/21/2014] [Indexed: 11/29/2022]
Affiliation(s)
- A Rousseau
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France.
| | - A Labbé
- Services d'ophtalmologie, centre hospitalier national ophtalmologique des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| | - C Baudouin
- Services d'ophtalmologie, centre hospitalier national ophtalmologique des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| | - I Cochereau
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France
| | - E Gabison
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France
| | - S Doan
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France
| |
Collapse
|
29
|
Guindolet D, Amaouche N, Doan S, Cochereau I, Gabison É. Mucous Fishing Syndrome : à propos d’un cas et revue de la littérature. J Fr Ophtalmol 2015; 38:e47-8. [DOI: 10.1016/j.jfo.2014.04.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2014] [Revised: 04/21/2014] [Accepted: 04/23/2014] [Indexed: 11/28/2022]
|
30
|
Poirier E, Soued I, Alexandre M, Boussoura S, Lamberto C, Uzunhan Y, Gharbi N, Pascal F, Doan S, Brillet PY, Caux F, Laroche L, Prost-Squarcioni C. Pemphigoïde des muqueuses avec sténoses laryngées ou trachéales : série de 11 cas. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
31
|
Doan S, Bertrand KC, Ma JCS, Chauhan A, Warrier R. Leukocytosis in an infant with Down syndrome. Clin Pediatr (Phila) 2014; 53:804-6. [PMID: 24658909 DOI: 10.1177/0009922814527510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Sylvia Doan
- University of Queensland School of Medicine, Brisbane, Queensland, Australia
| | - Kelsey C Bertrand
- University of Queensland School of Medicine, Brisbane, Queensland, Australia
| | - Jenson C S Ma
- University of Queensland School of Medicine, Brisbane, Queensland, Australia
| | - Aman Chauhan
- Louisiana State University Health Sciences Center, New Orleans, LA, USA
| | | |
Collapse
|
32
|
Alexandre M, Le Roux C, Doan S, Soued I, Pascal F, Heller M, Lièvre N, Caux F, Laroche L, Prost C. Morbidité à un an de la pemphigoïde cicatricielle : étude rétrospective sur 60 cas. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
33
|
Affiliation(s)
- Kelsey C Bertrand
- 1University of Queensland School of Medicine, Brisbane, Queensland, Australia
| | | | | |
Collapse
|
34
|
Abstract
Young children are most likely to travel to developing countries with their parents to visit relatives. Preparation for such travel must include careful counseling and optimal use of preventive vaccines and chemoprophylaxis. For infants and very young children, data defining safety and efficacy of these agents are often limited. However, accumulated experience suggests that young travelers may be managed similarly to older children and adults.
Collapse
Affiliation(s)
- Sylvia Doan
- University of Queensland, Brisbane, Queensland, Australia
| | | |
Collapse
|
35
|
Munyangango E, Le Roux-Villet C, Doan S, Pascal F, Soued I, Alexandre M, Heller M, Lièvre N, Aucouturier F, Caux F, Laroche L, Prost-Squarcioni C. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid. Br J Dermatol 2013; 168:381-90. [DOI: 10.1111/bjd.12041] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|
36
|
Leonardi A, Bogacka E, Fauquert JL, Kowalski ML, Groblewska A, Jedrzejczak-Czechowicz M, Doan S, Marmouz F, Demoly P, Delgado L. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy 2012; 67:1327-37. [PMID: 22947083 DOI: 10.1111/all.12009] [Citation(s) in RCA: 131] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/20/2012] [Indexed: 12/28/2022]
Abstract
Ocular allergy includes several clinically different conditions that can be considered as hypersensitivity disorders of the ocular surface. The classification of these conditions is complex, and their epidemiology has not been adequately studied because of the lack of unequivocal nomenclature. Ocular allergy symptoms are often, but not always, associated with other allergic manifestations, mostly rhinitis. However, specific ocular allergic diseases need to be recognized and managed by a team that includes both an ophthalmologist and an allergist. The diagnosis of ocular allergy is usually based on clinical history and signs and symptoms, with the support of in vivo and in vitro tests when the identification of the specific allergic sensitization is required for patient management. The aims of this Task Force Report are (i) to unify the nomenclature and classification of ocular allergy, by combining the ophthalmology and allergy Allergic Rhinitis and its Impact on Asthma criteria; (ii) to describe current methods of diagnosis; (iii) to summarize the therapeutic options for the management of ocular allergic inflammation.
Collapse
Affiliation(s)
- A. Leonardi
- Department of Neuroscience; Ophthalmology Unit; University of Padua; Padua; Italy
| | - E. Bogacka
- Department of Internal Medicine, Allergy and Geriatrics; Medical Academy of Wrocław; Wrocław; Poland
| | - J. L. Fauquert
- Unité d'Allergologie de l'enfant; CHU Estaing; Clermont-Ferrand; France
| | - M. L. Kowalski
- Department of Immunology, Rheumatology and Allergy; Medical University of Lodz; Łódź; Poland
| | - A. Groblewska
- Department of Ophthalmology; Polish Mother's Memorial Hospital; Łódź; Poland
| | | | - S. Doan
- Hopital Bichat and Fondation A. de Rothschild; Paris; France
| | - F. Marmouz
- Pole sanitaire du Vexin; Pontoise; France
| | - P. Demoly
- Inserm U454 - IFR3; hôpital Arnaud-de-Villeneuve; Montpellier; France
| | - L. Delgado
- Faculty of Medicine; Department of Immunology; University of Porto; Porto; Portugal
| |
Collapse
|
37
|
Nicolau R, Doan S, Cochereau I. [Sunset (Morgagnian) cataract]. J Fr Ophtalmol 2012; 35:391. [PMID: 22464866 DOI: 10.1016/j.jfo.2011.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2011] [Accepted: 11/22/2011] [Indexed: 10/28/2022]
Affiliation(s)
- R Nicolau
- Service d'ophtalmologie, fondation ophtalmologique Adolphe-de-Rothschild, 29, rue Manin, 75019 Paris, France.
| | | | | |
Collapse
|
38
|
Papo T, Klein I, Sacré K, Doan S, Bodaghi B, Aubart-Cohen F. Syndrome de Susac. Rev Med Interne 2012; 33:94-8. [DOI: 10.1016/j.revmed.2011.11.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2011] [Accepted: 11/03/2011] [Indexed: 11/16/2022]
|
39
|
Lee SC, Corradi N, Doan S, Dietrich FS, Keeling PJ, Heitman J. Evolution of the sex-related locus and genomic features shared in microsporidia and fungi. PLoS One 2010; 5:e10539. [PMID: 20479876 PMCID: PMC2866331 DOI: 10.1371/journal.pone.0010539] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2010] [Accepted: 04/15/2010] [Indexed: 12/31/2022] Open
Abstract
Background Microsporidia are obligate intracellular, eukaryotic pathogens that infect a wide range of animals from nematodes to humans, and in some cases, protists. The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it. Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes. Methodology/Principal Findings Here we expanded this analysis and also examined a putative sex-locus for variability between microsporidian populations. Whole genome inspection reveals a unique syntenic gene pair (RPS9-RPL21) present in the vast majority of fungi and the microsporidians but not in other eukaryotic lineages. Two other unique gene fusions (glutamyl-prolyl tRNA synthetase and ubiquitin-ribosomal subunit S30) that are present in metazoans, choanoflagellates, and filasterean opisthokonts are unfused in the fungi and microsporidians. One locus previously found to be conserved in many microsporidian genomes is similar to the sex locus of zygomycetes in gene order and architecture. Both sex-related and sex loci harbor TPT, HMG, and RNA helicase genes forming a syntenic gene cluster. We sequenced and analyzed the sex-related locus in 11 different Encephalitozoon cuniculi isolates and the sibling species E. intestinalis (3 isolates) and E. hellem (1 isolate). There was no evidence for an idiomorphic sex-related locus in this Encephalitozoon species sample. According to sequence-based phylogenetic analyses, the TPT and RNA helicase genes flanking the HMG genes are paralogous rather than orthologous between zygomycetes and microsporidians. Conclusion/Significance The unique genomic hallmarks between microsporidia and fungi are independent of sequence based phylogenetic comparisons and further contribute to define the borders of the fungal kingdom and support the classification of microsporidia as unusual derived fungi. And the sex/sex-related loci appear to have been subject to frequent gene conversion and translocations in microsporidia and zygomycetes.
Collapse
Affiliation(s)
- Soo Chan Lee
- Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America
| | - Nicolas Corradi
- Canadian Institute for Advanced Research, Department of Botany, University of British Columbia, Vancouver, Canada
| | - Sylvia Doan
- Canadian Institute for Advanced Research, Department of Botany, University of British Columbia, Vancouver, Canada
| | - Fred S. Dietrich
- Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America
- Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America
| | - Patrick J. Keeling
- Canadian Institute for Advanced Research, Department of Botany, University of British Columbia, Vancouver, Canada
| | - Joseph Heitman
- Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America
- * E-mail:
| |
Collapse
|
40
|
Lidove O, Chauveheid MP, Caillaud C, Froissart R, Benoist L, Alamowitch S, Doan S, Szalat R, Baumann N, Alexandra JF, Lavallée P, Klein I, Vuillemet F, Sedel F, Sacré K, Samson Y, Roullet E, Papo T. Aseptic meningitis and ischaemic stroke in Fabry disease. Int J Clin Pract 2009; 63:1663-7. [PMID: 19832823 DOI: 10.1111/j.1742-1241.2009.02115.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Fabry disease (OMIM 301 500) is an X-linked lysosomal storage disease. Neurological symptoms in Fabry disease mainly include stroke, acroparesthesia, cranial nerve palsies and autonomic dysfunction. We report on aseptic meningitis in Fabry patients. METHODS Clinical analysis, brain magnetic resonance imaging, cerebrospinal fluid analysis, treatment and outcome data were analysed in three cases of meningitis associated with Fabry disease. FINDINGS Mean age at meningitis onset was 26.6 (24-28) years. Headache was present in all cases and fever in two cases. Meningitis was always diagnosed before Fabry disease. A familial history of Fabry disease was present in two cases. Non-neurological symptoms caused by Fabry disease were present in all cases. All patients also suffered stroke and sensorineural hearing loss. Cerebrospinal fluid (CSF) analysis showed pleocytosis (mean, 36; range: 8-76 cells/mm(3)) and a high protein level (mean, 63; range, 47-70 mg/dl). C-reactive protein blood levels and erythrocyte sedimentation rate were raised. Diagnosis was assessed by low alpha-galactosidase A dosage and/or gene mutation analysis in all cases. All patients were treated with enzyme replacement therapy (ERT). In two cases, lumbar puncture was repeatedly performed and there was no normalisation of CSF under ERT alone, at 9 and 24 months of follow-up, respectively. One patient who suffered intracranial hypertension was treated efficiently with steroids, associated with azathioprine. The fact that Fabry disease could be an auto-inflammatory disorder is discussed. INTERPRETATION Fabry disease may cause aseptic meningitis.
Collapse
Affiliation(s)
- O Lidove
- Department of Internal Medicine, Hôpital Bichat Claude-Bernard, 75877 Paris, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
|
42
|
Zribi H, Descamps V, Hoang-Xuan T, Crickx B, Doan S. Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol 2009; 23:489-90. [PMID: 18721214 DOI: 10.1111/j.1468-3083.2008.02933.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
43
|
Gabison E, Chastang P, Doan S, Catanese M, Hoang-Xuan T, Cochereau I. 310 Greffes lamellaires cornéo-sclérales dans la prise en charge des amincissements cornéens périphériques immunologiques et dégénératifs : à propos de 10 cas. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73433-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
44
|
Brousseau B, Delcampe A, Gueudry J, Vera L, Doan S, Hoang-Xuan T, Muraine M. 319 Amélioration de la qualité de vie des patients atteints de Syndrome de Lyell ou de Steven-Johnson après adaptation de lentilles sclérales perméables. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73442-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
45
|
Alessi G, Doan S, Ltief Y, Gabison E, Papo T, Cochereau I, Lidove O. 398 Atteintes ophtalmologiques de la maladie de Fabry. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73522-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
46
|
Lemarinel B, Gabison E, Doan S, Teyssot N, Hoang-Xuan T. Intérêt de l’angiographie de segment antérieur au vert d’indocyanine dans la prise en charge des sclérites antérieures : à propos de 5 cas et revue de la littérature. J Fr Ophtalmol 2008; 31:495-501. [DOI: 10.1016/s0181-5512(08)72466-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
47
|
Brousseau B, Delcampe A, Gueudry J, Laroche J, Brasseur G, Doan S, Hoang-Xuan T, Muraine M. 322 Indication des verres scléraux perméables à l’oxygène. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70919-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
48
|
Gabison E, Doan S, Abitbol O, Hoang-Xuan T. 269 Kératites herpétiques multi récidivantes : mauvaise observance, corticodépendance ou résistance à l’acyclovir ? À propos de 15 cas. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70866-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
49
|
Doan S, Mgaieth K, Abitbol O, Gatinel D, Hoang-Xuan T, Gabison E. 287 Atopie et kératoconjonctivite vernale. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70884-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
50
|
Streho M, Gabison E, Abitbol O, Gatinel D, Hoang-Xuan T, Doan S. 626 Blépharite séborrhéique sévère avec complications cornéennes chez 2 patients séropositifs pour le VIH sous trithérapie anti-rétrovirale. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)71225-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|